Liver transplantation for glycogen storage disease type Ia

Srinevas K. Reddy, Stephanie L. Austin, Michele Spencer-Manzon, Dwight D. Koeberl, Bryan M. Clary, Dev M. Desai, Alastair D. Smith, Priya S. Kishnani

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background/Aims: Hepatocellular carcinoma (HCC) most often occurs within hepatocellular adenomas (HCAs) in glycogen storage disease Ia (GSD Ia) patients. The objective of this retrospective study is to assess outcomes after liver transplantation (LT) for GSD Ia where the principal indication for transplantation was prevention of HCC. Methods: Petitions to the United Network for Organ Sharing region 11 review board for additional model for end-stage liver disease listing points were made on behalf of GSD Ia patients. Demographics, pre-operative comorbidity, and outcomes for GSD Ia patients who underwent LT were reviewed. Results: Between 2004 and 2006, five GSD Ia patients underwent LT. Multiple HCAs with focal hemorrhage and/ or necrosis but without histological evidence of malignancy were identified in all explanted specimens. Four of five patients had complications after LT, including cytomegalovirus (CMV) infections and steroid responsive allograft rejection. Hemoglobin levels and serum triglyceride, total cholesterol, blood glucose, and lactic acid concentrations improved in all patients after LT. Corn starch feeding was not required in any patient after LT. Renal function worsened in three patients despite modifications to primary immunosuppressive medications. All patients are alive at last follow-up (range 25-48 months) and all post-transplant complications have resolved. Conclusions: By removing all possible adenomatous tissue and reversing the underlying hepatic enzymatic deficiency, LT provides definitive prevention against HCC and correction of most metabolic derangements in GSD Ia patients. Renal dysfunction secondary to GSD Ia persists-underscoring the need for further studies to better understand the mechanisms of renal dysfunction in these patients.

Original languageEnglish (US)
Pages (from-to)483-490
Number of pages8
JournalJournal of Hepatology
Volume51
Issue number3
DOIs
StatePublished - Sep 2009

Fingerprint

Glycogen Storage Disease
Liver Glycogen
Liver Transplantation
Liver Cell Adenoma
Hepatocellular Carcinoma
Kidney
End Stage Liver Disease
Cytomegalovirus Infections
Immunosuppressive Agents
Starch
Zea mays
Allografts
Blood Glucose
Comorbidity
Lactic Acid
Hemoglobins
Triglycerides
Necrosis
Retrospective Studies
Transplantation

Keywords

  • Glycogen storage disease Ia
  • Hepatocellular adenoma
  • Hepatocellular carcinoma
  • Liver transplantation

ASJC Scopus subject areas

  • Hepatology

Cite this

Reddy, S. K., Austin, S. L., Spencer-Manzon, M., Koeberl, D. D., Clary, B. M., Desai, D. M., ... Kishnani, P. S. (2009). Liver transplantation for glycogen storage disease type Ia. Journal of Hepatology, 51(3), 483-490. https://doi.org/10.1016/j.jhep.2009.05.026

Liver transplantation for glycogen storage disease type Ia. / Reddy, Srinevas K.; Austin, Stephanie L.; Spencer-Manzon, Michele; Koeberl, Dwight D.; Clary, Bryan M.; Desai, Dev M.; Smith, Alastair D.; Kishnani, Priya S.

In: Journal of Hepatology, Vol. 51, No. 3, 09.2009, p. 483-490.

Research output: Contribution to journalArticle

Reddy, SK, Austin, SL, Spencer-Manzon, M, Koeberl, DD, Clary, BM, Desai, DM, Smith, AD & Kishnani, PS 2009, 'Liver transplantation for glycogen storage disease type Ia', Journal of Hepatology, vol. 51, no. 3, pp. 483-490. https://doi.org/10.1016/j.jhep.2009.05.026
Reddy SK, Austin SL, Spencer-Manzon M, Koeberl DD, Clary BM, Desai DM et al. Liver transplantation for glycogen storage disease type Ia. Journal of Hepatology. 2009 Sep;51(3):483-490. https://doi.org/10.1016/j.jhep.2009.05.026
Reddy, Srinevas K. ; Austin, Stephanie L. ; Spencer-Manzon, Michele ; Koeberl, Dwight D. ; Clary, Bryan M. ; Desai, Dev M. ; Smith, Alastair D. ; Kishnani, Priya S. / Liver transplantation for glycogen storage disease type Ia. In: Journal of Hepatology. 2009 ; Vol. 51, No. 3. pp. 483-490.
@article{7966f001c29041d0a48947142a7abacf,
title = "Liver transplantation for glycogen storage disease type Ia",
abstract = "Background/Aims: Hepatocellular carcinoma (HCC) most often occurs within hepatocellular adenomas (HCAs) in glycogen storage disease Ia (GSD Ia) patients. The objective of this retrospective study is to assess outcomes after liver transplantation (LT) for GSD Ia where the principal indication for transplantation was prevention of HCC. Methods: Petitions to the United Network for Organ Sharing region 11 review board for additional model for end-stage liver disease listing points were made on behalf of GSD Ia patients. Demographics, pre-operative comorbidity, and outcomes for GSD Ia patients who underwent LT were reviewed. Results: Between 2004 and 2006, five GSD Ia patients underwent LT. Multiple HCAs with focal hemorrhage and/ or necrosis but without histological evidence of malignancy were identified in all explanted specimens. Four of five patients had complications after LT, including cytomegalovirus (CMV) infections and steroid responsive allograft rejection. Hemoglobin levels and serum triglyceride, total cholesterol, blood glucose, and lactic acid concentrations improved in all patients after LT. Corn starch feeding was not required in any patient after LT. Renal function worsened in three patients despite modifications to primary immunosuppressive medications. All patients are alive at last follow-up (range 25-48 months) and all post-transplant complications have resolved. Conclusions: By removing all possible adenomatous tissue and reversing the underlying hepatic enzymatic deficiency, LT provides definitive prevention against HCC and correction of most metabolic derangements in GSD Ia patients. Renal dysfunction secondary to GSD Ia persists-underscoring the need for further studies to better understand the mechanisms of renal dysfunction in these patients.",
keywords = "Glycogen storage disease Ia, Hepatocellular adenoma, Hepatocellular carcinoma, Liver transplantation",
author = "Reddy, {Srinevas K.} and Austin, {Stephanie L.} and Michele Spencer-Manzon and Koeberl, {Dwight D.} and Clary, {Bryan M.} and Desai, {Dev M.} and Smith, {Alastair D.} and Kishnani, {Priya S.}",
year = "2009",
month = "9",
doi = "10.1016/j.jhep.2009.05.026",
language = "English (US)",
volume = "51",
pages = "483--490",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Liver transplantation for glycogen storage disease type Ia

AU - Reddy, Srinevas K.

AU - Austin, Stephanie L.

AU - Spencer-Manzon, Michele

AU - Koeberl, Dwight D.

AU - Clary, Bryan M.

AU - Desai, Dev M.

AU - Smith, Alastair D.

AU - Kishnani, Priya S.

PY - 2009/9

Y1 - 2009/9

N2 - Background/Aims: Hepatocellular carcinoma (HCC) most often occurs within hepatocellular adenomas (HCAs) in glycogen storage disease Ia (GSD Ia) patients. The objective of this retrospective study is to assess outcomes after liver transplantation (LT) for GSD Ia where the principal indication for transplantation was prevention of HCC. Methods: Petitions to the United Network for Organ Sharing region 11 review board for additional model for end-stage liver disease listing points were made on behalf of GSD Ia patients. Demographics, pre-operative comorbidity, and outcomes for GSD Ia patients who underwent LT were reviewed. Results: Between 2004 and 2006, five GSD Ia patients underwent LT. Multiple HCAs with focal hemorrhage and/ or necrosis but without histological evidence of malignancy were identified in all explanted specimens. Four of five patients had complications after LT, including cytomegalovirus (CMV) infections and steroid responsive allograft rejection. Hemoglobin levels and serum triglyceride, total cholesterol, blood glucose, and lactic acid concentrations improved in all patients after LT. Corn starch feeding was not required in any patient after LT. Renal function worsened in three patients despite modifications to primary immunosuppressive medications. All patients are alive at last follow-up (range 25-48 months) and all post-transplant complications have resolved. Conclusions: By removing all possible adenomatous tissue and reversing the underlying hepatic enzymatic deficiency, LT provides definitive prevention against HCC and correction of most metabolic derangements in GSD Ia patients. Renal dysfunction secondary to GSD Ia persists-underscoring the need for further studies to better understand the mechanisms of renal dysfunction in these patients.

AB - Background/Aims: Hepatocellular carcinoma (HCC) most often occurs within hepatocellular adenomas (HCAs) in glycogen storage disease Ia (GSD Ia) patients. The objective of this retrospective study is to assess outcomes after liver transplantation (LT) for GSD Ia where the principal indication for transplantation was prevention of HCC. Methods: Petitions to the United Network for Organ Sharing region 11 review board for additional model for end-stage liver disease listing points were made on behalf of GSD Ia patients. Demographics, pre-operative comorbidity, and outcomes for GSD Ia patients who underwent LT were reviewed. Results: Between 2004 and 2006, five GSD Ia patients underwent LT. Multiple HCAs with focal hemorrhage and/ or necrosis but without histological evidence of malignancy were identified in all explanted specimens. Four of five patients had complications after LT, including cytomegalovirus (CMV) infections and steroid responsive allograft rejection. Hemoglobin levels and serum triglyceride, total cholesterol, blood glucose, and lactic acid concentrations improved in all patients after LT. Corn starch feeding was not required in any patient after LT. Renal function worsened in three patients despite modifications to primary immunosuppressive medications. All patients are alive at last follow-up (range 25-48 months) and all post-transplant complications have resolved. Conclusions: By removing all possible adenomatous tissue and reversing the underlying hepatic enzymatic deficiency, LT provides definitive prevention against HCC and correction of most metabolic derangements in GSD Ia patients. Renal dysfunction secondary to GSD Ia persists-underscoring the need for further studies to better understand the mechanisms of renal dysfunction in these patients.

KW - Glycogen storage disease Ia

KW - Hepatocellular adenoma

KW - Hepatocellular carcinoma

KW - Liver transplantation

UR - http://www.scopus.com/inward/record.url?scp=68049116914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68049116914&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2009.05.026

DO - 10.1016/j.jhep.2009.05.026

M3 - Article

C2 - 19596478

AN - SCOPUS:68049116914

VL - 51

SP - 483

EP - 490

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 3

ER -